$Anew Medical (WENA.US)$ ANEW MEDICAL, INC. Strengthens Inte...
$Anew Medical (WENA.US)$ ANEW MEDICAL, INC. Strengthens Intellectual Property Protection by Issuing a US Patent for an RNA Splicing Variant Secreted by the Human Klotho Gene for the Treatment of Neurodegenerative and Age-Related Diseases
(ANEW MEDICAL, INC. NASDAQ: WENA) has obtained a US patent number 12,036,268 because of the RNA splicing variant of the human Klotho gene it secretes, known as “s-KL.”
The patent strengthens ANEW's intellectual property protection in developing treatments for neurodegenerative and age-related diseases.
The Klotho gene, commonly known as an “anti-aging” gene, controls various brain and nervous system functions.
(ANEW MEDICAL, INC. NASDAQ: WENA) has obtained a US patent number 12,036,268 because of the RNA splicing variant of the human Klotho gene it secretes, known as “s-KL.”
The patent strengthens ANEW's intellectual property protection in developing treatments for neurodegenerative and age-related diseases.
The Klotho gene, commonly known as an “anti-aging” gene, controls various brain and nervous system functions.
ANEW has exclusive global rights to develop and commercialize novel genetic methods for the treatment of diseases such as Alzheimer's, ALS, and Parkinson's disease.
The company's intellectual property portfolio has been licensed by the Autonomous University of Barcelona and the Catalan Institute of Advanced Studies. This US patent complements existing patents in Europe, China, and other Asian markets, and strengthens ANEW's global intellectual property position.
The company's intellectual property portfolio has been licensed by the Autonomous University of Barcelona and the Catalan Institute of Advanced Studies. This US patent complements existing patents in Europe, China, and other Asian markets, and strengthens ANEW's global intellectual property position.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
